Advertisement
Advertisement
DCOY
D
Decoy Therapeutics Inc. Common Stock
0.67
USDSponsored
+0.01
+0.76%
Mar 03, 15:54 UTC -5
Closed
After-Market
0.67
+0.01
+1.20%
DCOY Earnings Reports
Positive Surprise Ratio
No Data Available for DCOY
0%
Next Report
Date of Next Report
Mar 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$6.00
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
Decoy Therapeutics Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, DCOY reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -6.00 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -6.00 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Belite Bio, Inc - ADR
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.38
Surprise
+31.80%
Scholar Rock Holding Corporation Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.90
Actual
-$0.88
Surprise
+3.09%
Apogee Therapeutics, Inc. Common Stock
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$1.07
Actual
-$1.03
Surprise
+4.31%
Nuvation Bio Inc.
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.11
Surprise
-20.75%
Zymeworks Inc.
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.42
Actual
-$0.55
Surprise
-29.53%
uniQure N.V.
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.96
Actual
-$0.56
Surprise
+41.97%
Oculis Holding AG Ordinary shares
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.42
Actual
-$0.39
Surprise
+6.57%
Biohaven Ltd.
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$1.31
Actual
-$1.21
Surprise
+8.00%
UroGen Pharma Ltd. Ordinary Shares
Report Date
Mar 02, 2026 For Q4 25
Estimate
-$0.51
Actual
-$0.54
Surprise
-5.37%
Arcturus Therapeutics Holdings Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.72
Actual
-$1.03
Surprise
-41.60%
FAQ
What were Decoy Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Decoy Therapeutics Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Decoy Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Decoy Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 19, 2026.
What are the forecasts for Decoy Therapeutics Inc. Common Stock's next earnings report?
Based on --
analysts, Decoy Therapeutics Inc. Common Stock is expected to report EPS of -$6.00 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement